141 related articles for article (PubMed ID: 19220278)
21. Medicines for children licensed by the European Medicines Agency (EMEA): the balance after 10 years.
Ceci A; Felisi M; Baiardi P; Bonifazi F; Catapano M; Giaquinto C; Nicolosi A; Sturkenboom M; Neubert A; Wong I
Eur J Clin Pharmacol; 2006 Nov; 62(11):947-52. PubMed ID: 17021892
[TBL] [Abstract][Full Text] [Related]
22. The availability and age-appropriateness of medicines authorized for children in The Netherlands.
van Riet-Nales DA; de Jager KE; Schobben AF; Egberts TC; Rademaker CM
Br J Clin Pharmacol; 2011 Sep; 72(3):465-73. PubMed ID: 21477143
[TBL] [Abstract][Full Text] [Related]
23. Risk management strategies in the Physicians' Desk Reference product labels for pregnancy category X drugs.
Uhl K; Kennedy DL; Kweder SL
Drug Saf; 2002; 25(12):885-92. PubMed ID: 12241129
[TBL] [Abstract][Full Text] [Related]
24. Paediatric medicines research in the UK: how to move forward?
Wong I; Sweis D; Cope J; Florence A
Drug Saf; 2003; 26(8):529-37. PubMed ID: 12825967
[TBL] [Abstract][Full Text] [Related]
25. Prescription Pattern Monitoring and Off-label Use of Medicines in the Pediatric Department at Tertiary Care Teaching Hospital.
Pandey S; Yadav CK; Ghimire P; Shrestha AC
Kathmandu Univ Med J (KUMJ); 2020 Oct.-Dec.; 18(72):367-371. PubMed ID: 34165093
[TBL] [Abstract][Full Text] [Related]
26. Lack of drug preparations for use in children in Brazil.
Costa PQ; Rey LC; Coelho HL
J Pediatr (Rio J); 2009; 85(3):229-35. PubMed ID: 19452078
[TBL] [Abstract][Full Text] [Related]
27. Widespread off-label prescribing of topical but not systemic drugs for 350,000 paediatric outpatients in Stockholm.
Ufer M; Rane A; Karlsson A; Kimland E; Bergman U
Eur J Clin Pharmacol; 2003 Mar; 58(11):779-83. PubMed ID: 12634986
[TBL] [Abstract][Full Text] [Related]
28. Unlicensed and off-label drug use in a paediatric ward of a general hospital in the Netherlands.
't Jong GW; van der Linden PD; Bakker EM; van der Lely N; Eland IA; Stricker BH; van den Anker JN
Eur J Clin Pharmacol; 2002 Jul; 58(4):293-7. PubMed ID: 12136376
[TBL] [Abstract][Full Text] [Related]
29. Stimulation programs for pediatric drug research--do children really benefit?
Boots I; Sukhai RN; Klein RH; Holl RA; Wit JM; Cohen AF; Burggraaf J
Eur J Pediatr; 2007 Aug; 166(8):849-55. PubMed ID: 17225950
[TBL] [Abstract][Full Text] [Related]
30. Usage of unpublished paediatric data.
Saint-Raymond A; Pelle B; Zaccaria C; Sennwitz M; Branch S
Arch Dis Child; 2016 Jan; 101(1):81-4. PubMed ID: 26543071
[TBL] [Abstract][Full Text] [Related]
31. Paediatric prescribing: using unlicensed drugs and medicines outside their licensed indications.
Collier J
Br J Clin Pharmacol; 1999 Jul; 48(1):5-8. PubMed ID: 10383552
[No Abstract] [Full Text] [Related]
32. Prescribing for off-label use and unauthorized medicines in three paediatric wards in Finland, the status before and after the European Union Paediatric Regulation.
Lindell-Osuagwu L; Hakkarainen M; Sepponen K; Vainio K; Naaranlahti T; Kokki H
J Clin Pharm Ther; 2014 Apr; 39(2):144-53. PubMed ID: 24329556
[TBL] [Abstract][Full Text] [Related]
33. Why are certain age bands used for children in paediatric studies of medicines?
Hoppu K; Fonseca H
Arch Dis Child; 2021 Jul; 106(7):631-635. PubMed ID: 33419728
[TBL] [Abstract][Full Text] [Related]
34. Off-label and unlicensed drug prescribing in three paediatric wards in Finland and review of the international literature.
Lindell-Osuagwu L; Korhonen MJ; Saano S; Helin-Tanninen M; Naaranlahti T; Kokki H
J Clin Pharm Ther; 2009 Jun; 34(3):277-87. PubMed ID: 19650250
[TBL] [Abstract][Full Text] [Related]
35. Drug prescribing. Licensing flaws.
Watts G
Health Serv J; 1999 Jan; 109(5639):suppl 9-11. PubMed ID: 10345648
[No Abstract] [Full Text] [Related]
36. Barriers to administering non-oral formulations in a paediatric population: A semi-structured interview study.
Venables R; Batchelor H; Stirling H; Marriott J
Int J Pharm; 2016 Jan; 497(1-2):12-7. PubMed ID: 26611666
[TBL] [Abstract][Full Text] [Related]
37. [The challenge of administering anti-tuberculosis treatment in infants and pre-school children. pTBred Magistral Project].
Piñeiro Pérez R; Santiago García B; Fernández Llamazares CM; Baquero Artigao F; Noguera Julian A; Mellado Peña MJ;
An Pediatr (Barc); 2016 Jul; 85(1):4-12. PubMed ID: 26364849
[TBL] [Abstract][Full Text] [Related]
38. Primary health care physicians' prescribing patterns for children under five in Qassim, Saudi Arabia.
Jahan S; Al-Saigul AM; Hamdelsseed SA
Prim Health Care Res Dev; 2019 Jun; 20():e89. PubMed ID: 32799981
[TBL] [Abstract][Full Text] [Related]
39. Availability of Oral Formulations Labeled for Use in Young Children in Serbia, Germany and the USA.
Bajcetic M; Kearns GL; Jovanovic I; Brajovic M; van den Anker JN
Curr Pharm Des; 2015; 21(39):5668-73. PubMed ID: 26323413
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological research in pediatrics: From neonates to adolescents.
Rakhmanina NY; van den Anker JN
Adv Drug Deliv Rev; 2006 Apr; 58(1):4-14. PubMed ID: 16533543
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
